Background. Acidosis during early reperfusion is reported to be beneficial for myocardial stunning. We tested in 31 dogs the hypothesis that staged reperfusion is beneficial to myocardial stunning.
Methods and Results. Contractile dysfunction was observed 3 hours after the onset of reperfusion after 15 minutes of occlusion of the coronary artery. In the staged reperfusion, pH of the coronary venous blood was lower for 20 minutes and fractional shortening was significantly improved compared with the control reperfusion group. When we increased pH of the reperfused myocardium by an intracoronary infusion of sodium bicarbonate, beneficial effects of the staged reperfusion were abolished. Furthermore, an intracoronary infusion of hydrogen chloride, which mimicked the changes in pH in coronary venous blood of the staged reperfusion, attenuated myocardial stunning.
Conclusions. These results indicate that acidosis during staged reperfusion primarily attenuates myocardial stunning. This procedure is clinically applicable for attenuation of reperfusion injury. (Circulation 1991; 84:2135 -2145 E ven if ischemic heart muscle is reperfused before irreversible injury occurs, contractile function remains impaired for a long period, a phenomenon known as myocardial stunning.1'2 Several lines of evidence support the hypothesis that cellular Ca overload during ischemia and/or reperfusion constitutes a primary cause of myocardial stunning.3-12 Furthermore, activation of leukocytes is reported to cause myocardial stunning13"14 by free radical generation15"6 and microcirculatory disturbances. 17 Released catecholamine during ischemia18 is thought to cause myocardial hypercontraction during early reperfusion. The enhanced myocardial contraction may increase myocardial oxygen consumption, which may prolong the anaerobic myocardial metabolism during reperfusion. If these deleterious factors are attenuated, myocardial stunning may be markedly attenuated.
Acidosis during early reperfusion is one promising intervention to attenuate these deleterious factors.19-24 H+ inhibits Na-Ca exchange,25'26 slow inward Ca channels, [27] [28] [29] Ca2' release from the sarcoplasmic reticulum,30'31 and binding of Ca24 to troponin C.32, 33 The inhibition of an increase in cytosolic Ca24 caused by acidosis may attenuate Ca overload during reperfusion and consequently myocardial stunning. Furthermore, acidosis is reported to attenuate the neutrophil activation and generation of free radicals,34 and acidosis attenuates myocardial contractility,35 both of which may also contribute to the attenuation of myocardial stunning. If transient acidosis is produced during reperfusion, contractile dysfunction is predominantly improved without any aftereffect of acidosis. Acidosis also augments the effects of adenosine,36 which may attenuate the severity of myocardial stunning.37'38 Indeed, acidosis during early reperfusion is reported to attenuate myocardial stunning in the ferret Langendorff preparations. 24 In the in situ heart, one strategy to produce transient acidosis during reperfusion is staged reperfusion. [39] [40] [41] [42] We examined staged reperfusion in dogs to test the beneficial effects on myocardial stunning. Because a long period of residual critical stenosis of the coronary artery after reperfusion is reported to be deleterious, [43] [44] [45] In the preliminary study, we observed that an intracoronary administration of HCl (82 ,gmol/kg/ min) decreased FS from 23+1% to 11±2% (n=5) in the nonischemic control conditions.
In these protocols, the perfusion area was determined by injection of Evans blue dye in the bypass tube. The mean tissue weights of the perfused area in the control reperfusion, staged reperfusion, staged reperfusion with NaHCO3, and HCl reperfusion groups were 38±5, 33±4, 39±4, and 35±4 g, respectively.
Chemical Analysis
Coronary arterial and venous blood oxygen difference (AVo2D) was assessed by the difference between coronary arterial and venous oxygen contents. Myocardial oxygen consumption (MVo2) (ml/100 g/min) was calculated by CBF (ml/100 g/min)xAVo2D (ml/ dl). Lactate was assessed by enzymatic assay,49 and lactate extraction ratio (LER) was obtained by coronary arteriovenous difference in lactate concentration multiplied by 100 and divided by arterial lactate concentration.5051
A TP Measurement
The method of ATP measurement has been previously described.48 After the last hemodynamic and metabolic measurements, small myocardial samples of LAD and LCx coronary arterial areas were removed (40-100 mg) and frozen with precooled stainless steel scissors and tongs in liquid nitrogen, and immediately stored at -80°C in liquid nitrogen. The frozen myocardial tissue was powdered and homogenized at 4°C in 1 ml of ice-cold 6% trichloroacetic acid, and then centrifuged at 2,500g for 20 minutes. The supernatant fluid was removed and extracted three times with 3 ml of diethyl ether saturated with water and stored in the freezer (-80°C). A luciferine-luciferase solution was prepared by dissolving FLE-50 (Sigma Co.) in 10 ml of distilled water, followed by centrifugation at 8,000g in ice-cold temperature for 1 hour. Supernatant (0.2 ml) was added to 5 ml of the ATP standard solution or ATP extract of myocardium, and the intensity of bioluminescence generated from the ATP luciferine-luciferase mixture was measured with a bioluminescence reader.
The ATP standard solution was prepared by diluting ATP-2 Na salts with distilled water. The ATP concentration was computed from the intensity of chemiluminescence.
Statistical Analysis
Statistical analysis was performed with paired and unpaired t tests. 52 The repeated-measures analysis of variance was also used to test the difference of each parameter versus time between the two groups. All values were expressed as mean+SEM, and a value of p<0.05 was considered significant.
Results
Before myocardial ischemia, there were no significant changes in regional FS and metabolic parameters between the control reperfusion condition, the staged reperfusion conditions with and without infusion of NaHCO3, and the acidotic reperfusion condition (Tables 1 and 2 , Figures 1, 2 , 5, and 7).
During ischemia, FS in each group decreased to identical extents and no significant differences were observed in both FS at 15 minutes of ischemia and time courses in the FS decline (Figures 1, 2 , 5, and 7). Heart rate in each group did not significantly change during ischemia and reperfusion (control, 134±4 beats per minute; 15 minutes of ischemia, 138+4 beats per minute; 180 minutes after reperfusion, 130±4 beats per minute). Table 2 shows that there were no significant changes in systemic hemodynamic parameters (LVP and dP/dtmn) between each group throughout the study. The extent of increases in end-diastolic pressure during ischemia was comparable in the four groups, and there were no significant changes in end-diastolic pressure in the control and at 3 hours of reperfusion.
Effects of Staged Reperfusion on Contractile
Dysfunction During Reperfusion Figure 1 shows the representative tracing of the systemic and regional hemodynamic parameters before, during, and after 15 minutes of coronary occlusion followed by abrupt reperfusion (control). Figure   2 shows the representative tracing of the hemodynamic parameters in the staged reperfusion group. In the groups in the staged reperfusion, the functional recovery (FS at 3 hours of reperfusion, 27.3%) was better than that in the control reperfusion group (FS at 3 hours of reperfusion, 10.7%; Figure 1 ). Figure 3 shows the changes in CPP (panel B) and CBF (panel C) after the onset of reperfusion. Abrupt coronary reperfusion returned CPP to the control level imme- diately and caused the marked coronary reactive hyperemic flow (peak flow, 325+27 ml/100 g/min at 15 seconds of reperfusion). When the coronary artery was gradedly reperfused with and without NaHCO3 (panel A, 40% of control CPP for 0-3 minutes after the onset of reperfusion, 60% of control CPP for 4-6 minutes, and 80% of control CPP for 7-10 minutes), the measured values of the CPP were consistent with the set values (panels A and B). Coronary reactive hyperemic flow in both of the staged reperfusion groups was significantly (p<0.001) attenuated for 6 minutes of reperfusion (panel C). Figure 4 shows the changes in pH in the coronary venous blood after the onset of reperfusion. In the control abrupt reperfusion condition; pH quickly returned to the normal condition; however, staged reperfusion significantly (p<0.001) prolonged acidosis up to 20 minutes. NaHCO3 administration returned low pH during the staged reperfusion to the levels of the control reperfusion condition. Indeed, NaHCO3 administration slightly increased pH in blood of the coronary vein 6 minutes after the onset of reperfusion. There were no significant changes in pH at 30 minutes of reperfusion with and without 10-minute administration of NaHCO3, indicating that the aftereffects of NaHCO3 administration disappear at 30 minutes of reperfusion. Figure 5 shows the time courses of FS after 15 minutes of ischemia in the control reperfusion group and the staged reperfusion groups with and without NaHCO3 infusion. Although FS was significantly (p<0.05) decreased in the staged reperfusion without NaHCO3 group compared with the control reperfusion groups up to 10 minutes of reperfusion, it was significantly (p<0.001) improved for 10-180 minutes of reperfusion. Staged reperfusion without NaHCO3 significantly (p<0.005) improved the contractile dysfunction at 3 hours of reperfusion compared with the control reperfusion group; however, this beneficial effect of staged reperfusion was abolished by the intracoronary infusion of NaHCO3 during reperfusion.
The changes in LER and MVo2 in these three groups are depicted in Tables 3 and 4 . There were no significant changes in LER during reperfusion with and without staged reperfusion. However, in the staged reperfusion group with NaHCO3, MVo2 during 30 minutes of reperfusion was significantly (p<0.05) attenuated compared with the control reperfusion and the staged reperfusion with NaHCO3 groups.
The coronary retrograde pressure and retrograde flow during ischemia were not different in the abrupt reperfusion (21.9+1.5 mm Hg and 3.6+0.5 ml/100 g/min), staged reperfusion (22.0+2.4 mm Hg and 3.4+0.8 ml/100 g/min), and staged reperfusion with NaHCO3 administration (23.0+2.3 mm Hg and 3.4+0.6 ml/100 g/min, respectively).
These results indicate that staged reperfusion significantly attenuates myocardial stunning and suggest that this beneficial effect of staged reperfusion is due to transient acidosis during reperfusion.
Role of Transient Acidosis in Improvement of Myocardial Stunning
Although we showed that staged reperfusion is beneficial for myocardial stunning possibly because Figure 6 shows the changes in pH of coronary venous blood. Intracoronary infusion of HCI up to 20 minutes of reperfusion significantly (p<0.001) decreased pH compared with the control reperfusion group, which is comparable with the staged reperfusion group. In accordance with this transient low pH, Figure 7 demonstrates that functional recovery 3 hours after reperfusion is significantly improved compared with the control reperfusion group, and the extent of improvement of FS in this group was comparable with that of the staged reperfusion group ( Figure 5 ). The reactive hyperemic flow was comparable with the abrupt reperfusion condition (peak flow, 346+29 ml/100 g/min at 15 seconds of reperfusion).
The coronary retrograde pressure and retrograde flow during ischemia were not different in the abrupt reperfusion (21.9±1.5 mm Hg and 3.6+0.5 ml/100 g/min) and acidosis reperfusion (22.2±2.3 mm Hg and 3.0±1.4 ml/100 g/min, respectively) groups.
These results strongly indicate that transient acidosis during early reperfusion attenuates myocardial stunning. Role ofATP in Improvement of Myocardial Stunning Table 5 shows the ATP contents in the control reperfused, staged reperfused, and acidotic reperfusion myocardium. In both the epicardial and endocardial myocardium, ATP content of the reperfused myocardium was significantly (p<0.001) lower than that in the nonischemic myocardium; however, the extents of decreases in ATP in these four groups were not significantly different.
Discussion
Prompt reperfusion of the acute ischemic myocardium is a primary and rational way of limiting the extent of eventual contractile dysfunction and myocardial necrosis. Recent phenomenon known as myocardial stunning. 1, 2 Reperfusion is reported to generate free radicals16,55 and cause Ca overload and overcontraction,7-12 either of which may be responsible for myocardial stunning.
In the present study, we showed evidence that staged reperfusion attenuates myocardial stunning and that the beneficial effect of staged reperfusion is attributed primarily to transient acidosis during early reperfusion. However, several lines of evidence suggest that graded reperfusion is deleterious to the reperfused myocardium. 43 4' In these studies, because the duration of limited coronary flow is rather long (>4 hours) compared with that of the present study, anaerobic myocardial metabolism caused by low-flow ischemia may be prolonged, which masks the beneficial effects of staged reperfusion. The staged reperfusion procedure in the present study was performed within 10 minutes, suggesting that anaerobic myocardial metabolism did not persist for a long period. Indeed, LER during early reperfusion in the staged reperfusion condition was not significantly different from that in the abrupt reperfusion group (Table 3) .
Mechanisms Wherein Staged Reperfusion Attenuates Myocardial Stunning
Although we concluded that transient acidosis during staged reperfusion primarily attenuates myocardial stunning, we need to consider other possibilities.
Low perfusion pressure during staged reperfusion procedures may affect myocardial contractility,56,57 which attenuates myocardial stunning. Increases in H' during staged reperfusion also attenuate myocardial contractility through competition of troponin C.32,33 This depressed cardiac contractility during staged reperfusion may preserve ATP contents of the reperfused myocardium, leading to an improvement of cardiac dysfunction. However, ATP contents of the reperfused myocardium were not significantly different between the control and staged reperfusion groups. Furthermore, the extent of recovery from ATP depletion does not necessarily determine the contractile dysfunction of stunned myocardium5,6,58 ' .-r fusion group. Since the damages caused by ischemia are inevitable even in the acidosis reperfusion groups, the late, more functional recovery after acidosis reperfusion suggests that acidosis may inhibit triggering mechanisms during early reperfusion.
Clinical Relevance and Limitations
Recent advances in coronary revascularization technique lead us to face a new aspect of myocardial injury.5354 Although the beneficial effects of early reperfusion are unquestionable, myocardial stunning can persist for days to weeks. This myocardial stunning may be one of the causes of acute heart failure in the ischemic, reperfused heart.1'2 Our results suggest that reperfusion injury can be attenuated because the maneuver in the present study attenuated myocardial stunning.
Our results merit further evaluation in realistic clinical settings. Percutaneous 
